Reports from Q4 2003 to Q1 2024 were analyzed using the OpenVigil 2.1 platform to identify male patients experiencing orgasmic dysfunction, erectile dysfunction, or decreased libido linked to GLP-1 receptor agonists (tirzepatide, semaglutide, dulaglutide, exenatide, lixisenatide, and liraglutide)
Making a Transition Transitioning from a compounded to an FDA-approved GLP-1 medication should be done under the guidance of a health care professional, Alyssa Billingsley, PharmD, director of pharmacy content at GoodRx, said, noting that such an individual can help the patient navigate any changes to the formulation, concentration, dosage, or delivery method
If dizziness persists, discuss with your healthcare provider before considering compression stockings or adjusting any blood pressure medications
Your baseline skin tone, age, and genetic factors all play roles in determining results